Article Text

PDF
GI Highlights from the literature
  1. Guruprasad P Aithal, JournalScan Editor
  1. Correspondence to Guruprasad P Aithal, Nottingham Digestive Disease Centre: Biomedical Research Unit, Consultant Hepatolobiliary Physician, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK; guru.aithal{at}nuh.nhs.uk

Statistics from Altmetric.com

Is ‘fatty liver’ a disease?

▶ Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med Published Online First: 2 Nov 2010. PMID: 21039302.

Although there is an acceptance that non-alcoholic fatty liver disease (NAFLD) is highly prevalent in the western population, there is still uncertainty regarding the natural history of NAFLD and its long-term clinical outcome. Consequently there are extreme views of its impact on public health.

Musso and colleagues performed a large scale literature review to identify 4185 articles of which 40 articles assessing the prognosis of NAFLD and its histological subtypes were included in the analysis. NAFLD was found to be associated with an increased pooled mortality compared to the general population (OR: 1.57, 95% CI 1.18 to 2.10), related to both liver and cardiovascular causes with a twofold increase in type 2 diabetes. Non-alcoholic steatohepatitis (NASH) had higher liver related mortality (OR 5.71, 2.31 to 14.13; OR NASH with advanced fibrosis: 10.06, 4.35 to 23.25) compared with simple steatosis, but cardiovascular mortality did not differ between steatosis and NASH. …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.